FMS Fresenius Medical Care AG & Co. KGaA
Healthcare$21.64+0.05%ClosedMarket Cap: $11.62B
As of 2026-05-25
Valuation
P/E (TTM)
13.92
PEG
0.17
P/B
0.78
P/S
0.52
EV/EBITDA
5.74
DCF Value
$91.58
FCF Yield
17.7%
Div Yield
4.0%
Margins & Returns
Gross Margin
26.0%
Operating Margin
10.2%
Net Margin
4.9%
ROE
7.2%
ROA
3.0%
ROIC
5.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $4.61B | 25.6% | $375.6M | $117.5M | $— | — |
| Q4 null | $5.07B | 27.4% | $549.0M | $327.1M | $— | — |
| FY null | $19.63B | 25.6% | $1.83B | $978.4M | $— | $0.79 |
| Q3 null | $4.88B | 25.4% | $501.7M | $274.8M | $— | — |
| Q2 null | $4.79B | 25.3% | $394.4M | $225.3M | $— | $0.79 |
| Q1 null | $4.88B | 24.3% | $381.7M | $151.2M | $— | — |
| Q4 null | $5.08B | 25.0% | $398.9M | $66.9M | $— | — |
| FY null | $19.34B | 24.6% | $1.47B | $537.9M | $— | $0.63 |
| Q3 null | $4.76B | 24.1% | $462.7M | $213.0M | $— | — |
| Q2 null | $4.77B | 24.5% | $425.0M | $187.0M | $— | $0.63 |
| Q1 null | $4.72B | 24.8% | $246.0M | $71.0M | $— | — |
| Q4 2023 | $4.99B | 27.1% | $427.6M | $187.9M | $0.22 | — |